Jim Simons Titan Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.26 - $0.48 $104 - $192	-400 Reduced 0.29%	135,310 $56,000
Q3 2023 Nov 14, 2023	BUY	$0.45 - $0.66 $45 - $66	100 Added 0.07%	135,710 $64,000
Q2 2023 Aug 11, 2023	BUY	$0.65 - $0.82 $130 - $164	200 Added 0.15%	135,610 $88,000
Q1 2023 May 12, 2023	BUY	$0.73 - $1.05 $730 - $1,050	1,000 Added 0.74%	135,410 $112,000
Q4 2022 Feb 13, 2023	SELL	$0.77 - $22.8 $7,931 - $234,840	-10,300 Reduced 7.12%	134,410 $105,000
Q3 2022 Nov 14, 2022	SELL	$0.53 - $22.6 $50,880 - $2.17 Million	-96,000 Reduced 39.88%	144,710 $156,000
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.94 $77,596 - $191,948	204,200 Added 559.3%	240,710 $135,000
Q1 2022 May 13, 2022	BUY	$0.89 - $1.26 $15,130 - $21,420	17,000 Added 87.13%	36,510 $35,000
Q4 2021 Feb 11, 2022	BUY	$1.02 - $1.93 $6,640 - $12,564	6,510 Added 50.08%	19,510 $20,000
Q3 2021 Nov 12, 2021	BUY	$1.87 - $2.57 $24,310 - $33,410	13,000 New	13,000 $24,000

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $49.4M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.